Provectus Biopharmaceuticals, Inc.: Form 8-K, filed Jun 21, 2024
Filed with the SEC on Jun 21, 2024 and accepted by EDGAR at Jun 21, 2024, 13:56 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-24-024661. Last ingested by Listed: Oct 30, 2026, 11:33 ET. Listed shows no prices and gives no investment advice.